Fetal RHD genotyping by analysis of maternal plasma in a mixed population

Journal of Clinical Laboratory Analysis

Volumn 25, Issue 2, 2011, Pages 100-104

  Amaral, Daphne R T ^a   Credidio, Débora C ^a   Pellegrino, Jordão ^a   Castilho, Lilian ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Fetal RHD genotyping; Multi ethnic population; Pregant women; RhD negative

Indexed keywords

RHESUS D ANTIBODY; TESTIS DETERMINING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BRAZIL; DIAGNOSTIC ACCURACY; ETHNIC GROUP; EXON; FEMALE; FETUS; GENETIC ASSOCIATION; GENOTYPE; GESTATIONAL AGE; HEMAGGLUTINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; NEWBORN; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREGNANT WOMAN; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; BRAZIL; DNA; ETHNIC GROUPS; FEMALE; FETAL BLOOD; GENETIC TESTING; GESTATIONAL AGE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM; YOUNG ADULT;

EID: 79952659560     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20440     Document Type: Article

References (27)

1. Machado IN, Castilho L, Pellegrino Jr J, Barini R. Fetal RhD genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras 2006;52:232-235.
2. Murray NA, Roberts IAG. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2007;92:83-88.
3. Müller SP, Bartels I, Stein W, et al. The determination of the fetal D status from maternal plasma for decision making on RH prophylaxis is feasible. Transfusion 2008;48:2292-2301.
4. Daniels G, Finning K, Martin P, Summers J. Fetal blood group genotyping: Present and future. Ann N Y Acad Sci 2006;1075:88-95.
5. Lo YMD, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738.
6. Costa JM, Giovangrandi Y, Ernaul P, et al. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255-260.
7. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: Introdution of a new noninvasive fetal RHD genotyping service. Transfusion 2002;42:1079-1085.
8. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004;1022:119-123.
9. Finning K, Martin P, Summers J, Massey E, Poole J, Daniels G. Effect of higt throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: Prospective feasibility study. Br Med J 2008;336:816-818.
10. Daniels G, Finning K, Martin P, Soothill P. Fetal blood group genotyping from DNA from maternal plasma: An important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 2004;87:225-232.
11. Faas BHW, Beuling EA, Christiaens GCML, Von Dem Borne AEGK, Van Der Schoot CE. Detection of fetal RHD-specific sequence in maternal plasma. Lancet 1998;352:1196.
12. Nelson M, Eagle C, Langshaw M, Popp H, Kronenberg H. Genotyping fetal DNA by non-invasive means: Extration from maternal plasma. Vox Sang 2001;80:112-116.
13. Johnson L, Mccracken SA, Morris JM, Woodland NB, Flowwer RL. Variation in the reliability of RHD antenatal genotyping using the polymerase chain reaction and targeting multiple exon of the RHD gene. Vox Sang 2003;85:222-223.
14. Siva SC, Johnson SI, Mccracken SA, Morris JM. Evaluation of the clinical usefulness of isolation of fetal DNA from the maternal circulation. AustNZ J Obstet Gynaecol 2003;43:105.
15. Zhang J, Fidler C, Murphy MF, Chamberlain PF, Sargent ILL, Redman CWG. Determination of fetal RhD status by maternal plasma DNA analysis. Ann N Y Acad Sci 2000;906:153-155.
16. Zhong XY, Holzgreve W, Hahn S. Risk free simultaneous prenatal identification of fetal rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly 2001;131:70-74.
17. Legler TJ, Lynen R, Maas JH, Pindur G, Kulenkampff D, Suren A. Prediction of fetal RhD and RhCE phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apheresis Sci 2002;27:217-223.
18. Turner MJ, Martin CM, O'leary JJ. Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care. Eur J Obstet Gynecol Reprod Biol 2003;108:29-32.
19. Rijnders RJP, Christiaens GCML, Bossers B, et al. Clinical applications of cell-free fetal DNA from maternal plasma. American College of Obst and Gynec 2004;103:157-164.
20. Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-18.
21. Minon JM, Senterre JM, Schaaps JP, Foldart JM. An unusual false-positive fetal RHD typing result using DNA derived from maternal plasma from solid organ transplant recipient. Transfusion 2006;46:1454-1455.
22. s gene in Brazilians with the D-negative phenotype. Braz J Med Biol Res 2002;35:767-773.
23. Pellegrino Jr J, Castilho L, Rios M, De Souza CA. Blood group genotyping in a population of highly diverse ancestry. J Clin Lab Anal 2001;15:8-13.
24. Finning K, Martin P, Daniels G. The use of maternal plasma for prenatal RhD blood group genotyping. Methods Mol Biol 2009;496:143-157.
25. Brojer E, Zupanska B, Guz K, Orzinska A, Kalinka A. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 2005;45:1473-1480.
26. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. J Histochem Cytochem 2005;53:301-305.
27. Daniels G, Finning K, Martin P, Massey E. Noninvasive prenatal diagnosis of fetal blood group phenotypes: Current practice and future prospects. Prenat Diagn 2009;29:101-107.